Whitehawk Therapeutics, a clinical-stage oncology company, announced its participation in three major healthcare investor conferences in September 2026: Cantor Global Healthcare Conference on September 9, Wells Fargo Healthcare Conference on September 10, and Morgan Stanley Global Healthcare Conference on September 15. At Morgan Stanley, the CFO and Chief Scientific Officer will hold a fireside chat, which will be webcast live and available for replay. The company focuses on developing advanced antibody drug conjugate (ADC) cancer treatments, with a portfolio including HWK-007, HWK-016, and HWK-206, designed to improve treatment for difficult cancers. These ADCs use proprietary technology licensed from WuXi Biologics and Hangzhou DAC to enhance stability and effectiveness.
Nvidia has returned a record $26 billion to its shareholders after increasing its dividend by an extraordinary 2,400%. This massive payout highlights the company's strong financial position and commitment to rewarding investors. The significant divid...
The New York Stock Exchange (NYSE) delivered its daily pre-market update on September 2, 2026, highlighting Medifast's launch of the Metabolic Health Institute, signaling its shift from weight loss to broader metabolic health. Other news includes A10...
Immunic Inc will hold a virtual research and development day on September 9 focused on relapsing multiple sclerosis (MS). The event will feature company executives and MS specialists discussing vidofludimus calcium (IMU-838), an oral therapy under Ph...
Midnight Sun Mining has launched Phase Two of its exploration program at the Dumbwa copper deposit in Zambia, shifting from broad drilling to a targeted approach to expand higher-grade copper mineralization. Phase One completed nearly 75,000 metres o...
An analyst initiates coverage of Salesforce with a Buy rating and a $430 price target, citing AI as a growth driver rather than a threat. Key growth factors include monetization of Agentforce, Data 360, and Informatica adoption, alongside acceleratio...
